You are here: Industry Insights > Vaccine

News List

CDC: Only Half of U.S. Nursing Home Residents Have Received Boosters Drugs
December 15, 2021
As COVID-19 cases surge nationwide, only about half of fully vaccinated nursing home residents have received a vaccine booster dose, the U.S. Centers for Disease Control and Prevention reports.
Health Minister Mandaviya invites global investors from EXPO2020 to strengthen Make-in-India expresspharma
December 14, 2021
India is leading in the development and production of COVID vaccine and helping the world in the fight against Corona: Dr Mansukh Mandaviya, Union Minister of Health and Family Welfare...
Over 1.16b Chinese fully vaccinated against COVID-19 NMPA/Xinhua
December 14, 2021
Over 1.16 billion Chinese people have been fully vaccinated against COVID-19, a spokesperson for the National Health Commission said at a press conference on Dec 11.
Singapore HSA approves Pfizer-BioNTech’s shot for children Pharmaceutical-Technology
December 14, 2021
Singapore’s Health Sciences Authority (HSA) has approved the usage of Pfizer-BioNTech’s Covid-19 vaccine, Comirnaty, for the paediatric population of ages five to 11 years.
NewsPoints Billionaire’s Bet on Pfizer Vaccine for China Fails to Pay Off FirstWordPharma
December 13, 2021
Beijing is supporting a home-grown mRNA vaccine, allowing China's Walvax Biotechnology Co. to test its own experimental vaccine as a booster, Bloomberg reported.
FDA expands EUA to Covid-19 booster shot of Pfizer-BioNTech Pharmaceutical-Technology
December 13, 2021
The US Food and Drug Administration (FDA) has granted expanded emergency use authorization (EUA) to Pfizer and BioNTech’s Covid-19 booster vaccine for people aged 16 years and above.
FDA Approves Pfizer Boosters for Teens Aged 16 to 17 Drugs
December 10, 2021
The U.S. Food and Drug Administration on Thursday approved the emergency use of the Pfizer COVID-19 booster shots for Americans aged 16 and 17 years old.
COVID Booster Cuts Death Rate by 90%, Israeli Study Finds Drugs
December 09, 2021
Booster doses of Pfizer's coronavirus vaccine set recipients up to effectively withstand the ravages of both the Delta and Omicron variants, a group of new studies suggest.
UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response PharmaTimes
December 08, 2021
Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.
Hilleman Labs establishes Singapore's first pilot manufacturing facility for vaccine development CPhIonline
December 08, 2021
A 30,000-sq. ft cGMP facility and a separate R&D site will work alongside each other to provide end-to end product development solutions for Singapore and low- and middle-income countries

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page